By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MethylGene Inc. 

7220 Frederick-Banting
Suite 200
Montreal  Quebec  H4S 2A1  Canada
Phone: 514-337-3333 Fax: 514-337-0550


SEARCH JOBS




Collaborations

Merck & Co.  Antibacterials





Company News
Mirati Therapeutics and MethylGene Announce Completion of Plan of Arrangement 6/28/2013 10:47:33 AM
MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc. 6/25/2013 10:48:01 AM
MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology Annual Meeting 6/3/2013 9:54:26 AM
MethylGene to Present at the Jefferies and Co. 2013 Healthcare Conference 5/30/2013 10:05:19 AM
MethylGene to Present Mocetinostat Data at the 2013 American Society of Clinical Oncology Annual Meeting 5/28/2013 10:48:05 AM
MethylGene Reports First Quarter 2013 Financial Results 5/13/2013 11:03:31 AM
MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ 5/9/2013 9:56:27 AM
MethylGene Presents Preclinical Data on MG516 at the American Association for Cancer Research Annual Meeting 4/8/2013 11:56:09 AM
MethylGene Reports Results of Phase 2 Trial of MGCD290 3/18/2013 12:04:55 PM
MethylGene Announces Management Changes 3/14/2013 11:51:34 AM
12345678910...
//-->